Search
forResearch 10 of 355
- Alopecia areata in children:, response to treatment with diphencyprone
- Squarticles as a Lipid Nanocarrier for Delivering Diphencyprone and Minoxidil to Hair Follicles and Human Dermal Papilla Cells
- Squalene-Containing Nanostructured Lipid Carriers Promote Percutaneous Absorption and Hair Follicle Targeting of Diphencyprone for Treating Alopecia Areata
- Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study
- Vitiligo as a Reaction to Topical Treatment with Diphencyprone
- Vitiligo complicating diphencyprone sensitization therapy for alopecia universalis
- Retrospective review of diphencyprone in the treatment of alopecia areata
- Vitiligo after Diphencyprone for Alopecia Areata
- Diphencyprone and topical tacrolimus as two topical immunotherapeutic modalities. Are they effective in the treatment of alopecia areata among Egyptian patients? A study using CD4, CD8 and MHC II as markers
- Effects of diphencyprone on expression of Bcl-2 protein in patients with Alopecia areata
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →